Skip to main content Help with accessibility Skip to main navigation

EMPAGLIFLOZIN tablets (Jardiance®) for symptomatic chronic heart failure with reduced ejection fraction

CCG Approval Status:

Ha
Kn
Li
SF
SS
SH
Wa
WL
Wi
Date Added: 28 - Apr - 2022
Body System:
Amber recommended
EMPAGLIFLOZIN tablets (Jardiance®) for symptomatic chronic heart failure with reduced ejection fraction

The Pan Mersey Area Prescribing Committee recommends the prescribing of EMPAGLIFLOZIN tablets (Jardiance®) for symptomatic chronic heart failure with reduced ejection fraction, following specialist recommendation in accordance with NICE TA773.